
Schwall Pharma Private Limited
About Schwall Pharma Private Limited
Data last updated:
Schwall Pharma Private Limited was a private limited company based in Aurangabad, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the crop production segment of the agriculture sector. It was incorporated on 19 February 2013.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2013PTC240600. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was led by directors including Syed Asrar Viqaroddin Quadri and Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui.
Its last annual general meeting (AGM) was held on 30 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at P.No. 17 Gut No 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2017, the company reported a revenue of ₹9.29 Lakh, a growth of 72% compared to the previous year. For the same year it recorded a net profit of ₹11,485 (net margin 1.2%) and EBITDA of ₹61,989 (EBITDA margin 6.7%).
Company details
Contact details
Schwall Pharma Private Limited's registered office is in Aurangabad, Maharashtra.
- Registered AddressP.No. 17 Gut No 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, India – 431001
- IndustryAgriculture, Crop Production
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Schwall Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Schwall Pharma Private Limited, buy the company report.
Financials of Schwall Pharma Private Limited
FY 2017 filings availableSchwall Pharma Private Limited reported revenue of ₹9.29 Lakh (up 72% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 72% in the latest year. EBITDA rose 513% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹61,989 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹11,485 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.7% | ||
| Net Profit Margin | 1.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Schwall Pharma Private Limited, buy the company report.
Board of directors of Schwall Pharma Private Limited
Schwall Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Asrar Viqaroddin Quadri Also directs: Medi Schwall Pharma Private Limited | Director | 19 Feb 2013 | 13 Years 8 Months | As last reported |
| Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui Also directs: Medi Schwall Pharma Private Limited | Additional Director | 27 Sep 2013 | 13 Years 1 Months | As last reported |
| Tahura Siddiqui Mujahed Also directs: Medi Schwall Pharma Private Limited | Additional Director | 26 Aug 2015 | 11 Years 2 Months | As last reported |
| Kaziatiyabegam Sayedvikaroddin Kadri | Additional Director | 26 Aug 2015 | 11 Years 2 Months | As last reported |
Peer comparison
Schwall Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dharmik Infratech Private Limited | ₹9.3 Lakh (FY 2023) | 3.0% | Delhi, India | |||
| Malti Total Solution Private Limited | ₹9.29 Lakh (FY 2025) | 8.0% | Lucknow, Uttar Pradesh, India | |||
| Varuna Bottling Company Private Limited | ₹9.29 Lakh (FY 2024) | 103.0% | Bangalore, Karnataka, India | |||
| Ruia Exports Limited | ₹9.29 Lakh (FY 2024) | -59.0% | Mumbai, Maharashtra, India | |||
| Panitos Infratech Private Limited | ₹9.29 Lakh (FY 2021) | -60.0% | Noida, Uttar Pradesh, India | |||
| Schwall Pharma Private Limitedthis company | ₹9.29 Lakh (FY 2017) | ₹11,485 | 1.2% | 72.0% | Aurangabad, Maharashtra, India | |
| Sanyog Marketing Private Limited | ₹9.29 Lakh (FY 2024) | -40.0% | Raipur, Chhattisgarh, India | |||
| Creative Filaments Pvt Ltd | ₹9.29 Lakh (FY 2025) | 6.0% | Surat, Gujarat, India | |||
| Khandesh Lemon Farmer Producer Company Limited | ₹9.29 Lakh (FY 2023) | 30853.0% | Jalgaon, Maharashtra, India | |||
| Laichi (OPC) Private Limited | ₹9.28 Lakh (FY 2021) | -15.0% | Kolkata, West Bengal, India | |||
| Satgun Foods Private Limited | ₹9.28 Lakh (FY 2023) | 43.0% | Pune, Maharashtra, India |
To see the full peer comparison of Schwall Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Schwall Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Schwall Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Schwall Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Schwall Pharma Private Limited, buy the company report.
Recent activity
Schwall Pharma Private Limited has 5 board changes on record since 2013: 4 appointments and 1 cessation. The latest: Kayum Latif Pathan ceased to be Director on 26 Aug 2015.
Frequently asked questions
Schwall Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Schwall Pharma was a private limited company based in Aurangabad, Maharashtra, India. The company worked in crop production, within the agriculture industry. It was incorporated on 19 February 2013 and is registered under CIN U24233MH2013PTC240600. The company has been struck off by the Registrar of Companies and is no longer operational.
Schwall Pharma had 4 directors:
- Syed Asrar Viqaroddin Quadri - Director
- Mohammed Abdul Mateen Mohammed Abdul Bari Siddiqui - Additional Director
- Tahura Siddiqui Mujahed - Additional Director
- Kaziatiyabegam Sayedvikaroddin Kadri - Additional Director
The CIN (Corporate Identification Number) of Schwall Pharma is U24233MH2013PTC240600. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Schwall Pharma is at P.No. 17 Gut No 84 Latif Nagar Deolai Parisar, Aurangabad, Maharashtra, India – 431001.
Schwall Pharma was incorporated on 19 February 2013. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Schwall Pharma on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 30 September 2017. Year-wise statements from 2015 are in the company report.
No. Schwall Pharma has 1 GST registration on record and it is cancelled or inactive.
Schwall Pharma operated in the agriculture industry, in the crop production segment. It worked in this industry before it was struck off.
The peers of Schwall Pharma by revenue are Dharmik Infratech Private Limited, Malti Total Solution Private Limited, Varuna Bottling Company Private Limited, Ruia Exports Limited, Panitos Infratech Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Kayum Latif Pathan ceased to be Director on 26 Aug 2015. Kaziatiyabegam Sayedvikaroddin Kadri was appointed as Additional Director on 26 Aug 2015. Tahura Siddiqui Mujahed was appointed as Additional Director on 26 Aug 2015. Schwall Pharma has 5 board changes on record in total.

